Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

The Best of 2009
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all

Articles: Cardiac/Hypertension



Latest (5) Month's Top Read Top 50 of Year  
Receive free subspecialty "5-minute updates" via email

Prior Articles


An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension
Journal of the American Society of Hypertension, 12/14/09
Sponsor
Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09
Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09
Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy
Current Medical Research and Opinion, 12/10/09
Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09    Free full text
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Non-adherence to statin therapy: a major challenge for preventive cardiology
Expert Opinion in Pharmacotherapy, 12/08/09
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09
A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management
Pharmacoepidemiology and Drug Safety, 12/08/09
Exclusive Author Commentary
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/07/09    Free full text    Evidence Based Medicine
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09    Free full text    Evidence Based Medicine
Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease
Clinical Therapeutics, 12/07/09
Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: A cohort study
Clinical Therapeutics, 12/07/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09    Free full text
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09    Free full text
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Valsartan and aliskiren (Valturna): Combination of an angiotensin receptor blocker with direct renin inhibitor approved for the treatment of hypertension
Formulary, 12/02/09    Free full text
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09    Free full text

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    2      3      4      5      6      7      8      9      10      11      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.